Results 251 to 260 of about 244,575 (365)

Brain Derived Neurotrophic Factor as a Treatment Modality: The Future of Clinical Neurosciences

, 2018
Shah Faisal Ahmad Tarfarosh, Mohammad Faizan Bhat, Raheel Mushtaq, Mushbiq Manzoor, Sheikh Shoib   +4 more
openalex   +1 more source

Brain-Derived Neurotrophic Factor mRNA and Protein Are Targeted to Discrete Dendritic Laminas by Events That Trigger Epileptogenesis [PDF]

, 2004
Enrico Tongiorgi, Mara Armellin, Piero Giulio Giulianini, Gianni Bregola, Silvia Zucchini, Beatrice Paradiso, Oswald Steward, Antonino Cattaneo, Michele Simonato   +8 more
openalex   +1 more source

Mechanisms of spinal glial activation in chemotherapy‐induced peripheral neuropathy: Focus on microglia and astrocytes

Ibrain, EarlyView.
Chemotherapy‐induced peripheral neuropathy (CIPN) remains a major clinical challenge, with central sensitization considered an important pathological mechanism in its occurrence and persistence. This review focuses on spinal astrocytes and microglia, systematically summarizing the pathological mechanisms of spinal glial cells involved in CIPN caused by
Long Gu, Song Cao, Yonghuai Feng
wiley   +1 more source

Müller glia-mediated protection of retinal ganglion cells from ethambutol-induced neurotoxicity through brain-derived neurotrophic factor. [PDF]

Cell Commun Signal
Cheng HC, Wong YH, Wang AG, Chen SW, Yang YL, Juan HC, Liou RH, Yu JY.   +7 more
europepmc   +1 more source

Brain-Derived Neurotrophic Factor Induces Long-Term Potentiation in Intact Adult Hippocampus: Requirement for ERK Activation Coupled to CREB and Upregulation of Arc Synthesis

Journal of Neuroscience, 2002
S. Ying, M. Futter, K. Rosenblum, M. Webber, S. Hunt, T. Bliss, C. Bramham   +6 more
semanticscholar   +1 more source

Molecular imprinting for neurology: Materials, applications, and limitations

Ibrain, EarlyView.
Molecularly imprinted materials: diagnostic, therapeutic and research applications in neurology. Molecularly imprinted materials offer high specificity and affinity for target molecules in neurological applications. This review highlights their synthesis, characterisation, and use in diagnostics, research and therapeutics.
Xiaohan Ma, Yingqi Ma, Claudia Marino, Alessandro Poma   +3 more
wiley   +1 more source

Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease

Nature Medicine, 2009
A. Nagahara, D. Merrill, G. Coppola, Shingo Tsukada, B. E. Schroeder, G. Shaked, Ling Wang, A. Blesch, A. Kim, J. Conner, E. Rockenstein, M. Chao, E. Koo, D. Geschwind, E. Masliah, A. Chiba, M. Tuszynski   +16 more
semanticscholar   +1 more source

Brain Imaging Changes Following Deep Brain Stimulation Patients with Parkinson's Disease: A Literature Review

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Parkinson's Disease (PD) is a progressive neurodegenerative disorder primarily characterized by motor symptoms such as tremors, rigidity, and bradykinesia. Structural brain changes, including atrophy in the midbrain, basal ganglia, and cortical regions such as the frontal and temporal lobes, are observed in advanced stages.
Suraiya Mangra, Stanislaw Szlufik, Chao‐Kai Hu, Alexandre Boutet, Jürgen Germann, Andres M. Lozano   +5 more
wiley   +1 more source

Association of diabetes risk reduction diet (DRRD) score with metabolic health, brain-derived neurotrophic factor and adropin in Iranian adults. [PDF]

Nutr J
Rashki A, Moradmand Z, Shahdadian F, Rouhani P, Saneei P.   +4 more
europepmc   +1 more source

Uncovering the Complexity of Synucleinopathies: An Ongoing Tale Between Proteins and Lipids

Movement Disorders, EarlyView.
Abstract Neurodegenerative diseases are pathological states characterized by progressive alterations in brain homeostasis during aging. Synucleinopathies, including Parkinson's disease and dementia with Lewy bodies, are defined neuropathologically by the accumulation of inclusions known as Lewy bodies and Lewy neurites.
Manuel Flores‐León, Tiago F. Outeiro
wiley   +1 more source